BusinessSummit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018By Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessSummit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against GonorrhoeaBy Nasdaq OMXMar 13, 2018, 11:01 AM UTC
BusinessCempra Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXFeb 28, 2017, 11:45 AM UTC
BusinessCempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016By Nasdaq OMXAug 30, 2016, 1:15 PM UTC
BusinessCempra’s Pivotal Phase 3 SOLITAIRE-IV Study of IV to Oral Solithromycin Published in Clinical Infectious DiseasesBy Nasdaq OMXAug 25, 2016, 8:05 PM UTC
